Factual end-of-day data for AUROPHARMA: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 6,99,038 shares was close to the 20-day average.
AUROPHARMA's delivery share of 42.0% was below its 20-day average of 53.0%.
| Date | Close | Change | Volume | Delivered qty | Delivery % |
|---|---|---|---|---|---|
| 9 Oct 2026 | ₹1,693.00 | +2.92% | 6,99,038 | 2,93,643 | 42.0% |
| 8 Oct 2026 | ₹1,645.00 | -2.20% | 4,39,291 | 2,55,765 | 58.2% |
| 7 Oct 2026 | ₹1,682.00 | -0.64% | 4,38,151 | 2,16,221 | 49.4% |
| 6 Oct 2026 | ₹1,692.80 | +1.07% | 10,09,636 | 6,32,856 | 62.7% |
| 5 Oct 2026 | ₹1,674.90 | -0.11% | 9,58,714 | 5,29,534 | 55.2% |
| 1 Oct 2026 | ₹1,676.80 | +0.29% | 10,74,057 | 5,41,384 | 50.4% |
| 30 Sep 2026 | ₹1,672.00 | -1.51% | 11,38,610 | 5,81,710 | 51.1% |
| 29 Sep 2026 | ₹1,697.70 | +0.01% | 11,59,038 | 7,51,145 | 64.8% |
| 28 Sep 2026 | ₹1,697.50 | -0.85% | 6,57,590 | 3,89,437 | 59.2% |
| 25 Sep 2026 | ₹1,712.00 | -0.23% | 6,24,705 | 2,88,914 | 46.3% |
| 24 Sep 2026 | ₹1,716.00 | -0.32% | 8,19,753 | 3,70,956 | 45.3% |
| 23 Sep 2026 | ₹1,721.50 | +1.26% | 9,51,081 | 5,81,530 | 61.1% |
| 22 Sep 2026 | ₹1,700.00 | -0.78% | 8,69,831 | 5,21,307 | 59.9% |
| 21 Sep 2026 | ₹1,713.40 | -1.19% | 9,02,487 | 4,48,830 | 49.7% |
| 18 Sep 2026 | ₹1,734.00 | +2.60% | 12,09,478 | 6,78,997 | 56.1% |
| 17 Sep 2026 | ₹1,690.00 | +2.86% | 7,58,827 | 3,20,038 | 42.2% |
| 16 Sep 2026 | ₹1,643.00 | -1.02% | 5,22,849 | 2,48,750 | 47.6% |
| 15 Sep 2026 | ₹1,660.00 | -1.18% | 4,38,757 | 2,13,790 | 48.7% |
| 11 Sep 2026 | ₹1,679.80 | +0.68% | 4,94,251 | 2,06,844 | 50.4% |
| 10 Sep 2026 | ₹1,668.40 | -1.80% | 7,98,368 | 4,33,676 | 54.3% |
Compare with delivery percentage for all NSE stocks.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume.
Large-trade volume split: 34,895 shares on the buy side vs 16,194 on the sell side.
Largest single buy-side trade: 1,961 shares at ₹1,676.00.
| Indicator | Reading (9 Oct 2026) |
|---|---|
| RSI (14) | 53.3 |
| 50-day EMA | ₹1,650.00 — close is above |
| 200-day EMA | ₹1,464.39 — close is above |
| SuperTrend (10, 3) | ₹1,607.04 — close is above the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
AUROPHARMA is a large-cap NSE stock in the Pharma sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹69,412 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 9 Oct 2026, 42.0% of AUROPHARMA's traded volume was marked for delivery (2,93,643 shares delivered). The 20-day average delivery is 53.0%.
AUROPHARMA closed at ₹1,693.00 on 9 Oct 2026 (+2.92% vs the previous close).
52-week high ₹1,740.00, 52-week low ₹1,066.80. The latest close is -2.70% from the 52-week high.